Last reviewed · How we verify
IPV IM Device — Competitive Intelligence Brief
marketed
vaccine delivery device
Immunology / Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
IPV IM Device (IPV IM Device) — London School of Hygiene and Tropical Medicine. IPV IM Device is an intradermal delivery device designed to administer inactivated polio vaccine (IPV) via the intramuscular route with improved immunogenicity and reduced antigen requirements.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IPV IM Device TARGET | IPV IM Device | London School of Hygiene and Tropical Medicine | marketed | vaccine delivery device | ||
| IPV ID Needle | IPV ID Needle | London School of Hygiene and Tropical Medicine | marketed | Vaccine delivery device |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (vaccine delivery device class)
- London School of Hygiene and Tropical Medicine · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IPV IM Device CI watch — RSS
- IPV IM Device CI watch — Atom
- IPV IM Device CI watch — JSON
- IPV IM Device alone — RSS
- Whole vaccine delivery device class — RSS
Cite this brief
Drug Landscape (2026). IPV IM Device — Competitive Intelligence Brief. https://druglandscape.com/ci/ipv-im-device. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab